- Understanding Huntington protein aggregation in cell mimicking environments
- Gangliosides modulate the secretion of extracellular vesicles and their misfolded protein cargo
- Dietary patterns and fasting behaviors in Huntington's disease population: A cross-sectional survey study
- Neurotransmitters in Neural Circuits and Neurological Diseases
- Protein aggregation in neurodegenerative diseases
- Extrapolation before imputation reduces bias when imputing censored covariates
- Novel monoclonal antibodies against the C-terminal HEAT domain of Huntingtin
- Single-cell-scale spatial transcriptome of the developing and adult mouse ovary
- Patient-derived lymphocytes drive smoldering lesion pathology in a chimeric multiple sclerosis mouse model
- Targeting the Milieu in Neurodegenerative Disease: Time for "Imprecision Medicine"?
- Neuroprotective effects of candesartan in 3-nitropropionic acid-induced Huntington's disease: modulation of angiotensin and CREB/BDNF/PGC1-alpha signaling
- Epigenetic Dysregulation in Neurodegenerative Disease: Implications for Neuropathology and Therapy
- Coherent dynamics of thalamic head-direction neurons irrespective of input
- Nanotechnology for Neurodegenerative Diseases: Recent Progress in Brain-Targeted Delivery, Stimuli-Responsive Platforms, and Organelle-Specific Therapeutics
- Therapeutic potential of mesenchymal stem cells in neurodegenerative diseases
- Advancing Mitochondrial Health in Huntington Disease (HD): Small Molecule Therapies and Neurodegeneration
- Development of an Integrated Single-Cell and Spatial Transcriptomics Atlas of Healthy Human Skin Focusing on the Pilosebaceous Unit
- Granularity of thalamic head direction cells
- Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's disease
- A rare genetic variant confers resistance to neurodegeneration across multiple neurological disorders by augmenting selective autophagy
- Coiled-Coil Structures Mediate the Intercellular Propagation of Huntingtin
- Molecular Imbalances Between Striosome and Matrix Compartments Characterize the Pathogenesis and Pathophysiology of Huntington's Disease Model Mouse
- A Perspective on the Role of Mitochondrial Biomolecular Condensates (mtBCs) in Neurodegenerative Diseases and Evolutionary Links to Bacterial BCs
- Beyond Support Cells: Astrocytic Autophagy as a Central Regulator of CNS Homeostasis and Neurodegenerative Diseases
- Mapping the landscape of caregiver burden in Huntington's Disease: Current evidence and future directions
- Repurposed hnRNPC binds mature mRNAs and safeguards the mitotic transcriptome
- Digital speech assessments and machine learning for differentiation of neurodegenerative diseases
- The role of redox-active iron, copper, manganese, and redox-inactive zinc in toxicity, oxidative stress, and human diseases
- Hunting for an Answer: Misdiagnosis of Huntington's Disease as Schizophrenia
- Neuroinflammation across the spectrum of neurodegenerative diseases: mechanisms and therapeutic frontiers
- Membranes as targets and modifiers of mutant huntingtin aggregation
- Global transcriptional analysis of human FHs 74 Int intestinal epithelial cells after exposure to advanced glycation end products
- Potential repurposing of lapatinib and pazopanib as neuroprotective agents in a rat model of Huntington's disease
- Mutant huntingtin exon 1 protein detected in mouse brain with neoepitope antibody: effects of CAG repeat expansion, MutS Homolog 3 silencing and aggregation
- Novel small molecule derivatives improve survivability in the cellular model of Huntington's disease via improving mitochondrial fusion
- Letter in response to Fuller et al., Functional Rating Scale 2.0 (FuRST 2.0): A patient-reported outcome measure of function for Huntington's disease
- Inhibition of Hippo Signaling Through Ablation of Lats1 and Lats2 Protects Against Cognitive Decline in 5xFAD Mice via Increasing Neuronal Resilience Against Ferroptosis
- In Silico Identification of Natural SIRT1 Inhibitors through Molecular Docking, Dynamics Simulation, and MM/PBSA
- Using a Brief Body Sway Assessment Device to Track Balance Differences across the Huntington's Disease Integrated Staging System Spectrum
- Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention
- Exploring the Emerging Role of Stem Cell Therapy in Neurodegenerative Diseases and Spinal Cord Injury: A Narrative Review
- Broad-spectrum therapeutic potential of 4-phenylbutyrate in neurological and systemic diseases of viral and non-viral origin
- Exploring Thiophene-Based Pharmacophores as Emerging Therapeutics for Neurodegenerative Disorders
- Adjusting extracellular pH restores proteostasis and extends lifespan in a yeast model of polyglutamine toxicity
- Huntington's disease-like 2 patients' profile in a Brazilian cohort
- Contemporary trends in targeted protein degradation for neurodegenerative diseases
- Huntington's chorea: emerging fields in therapeutics (Review)
- Pridopidine in early-stage manifest Huntington's disease: a phase 3 trial
- Astrocyte Autophagy in Neurodegenerative Diseases: Current Progress in Mechanisms and Therapeutics
- Preliminary observations of glucose metabolism dysregulation in pediatric Huntington's disease
- Unraveling the Vicious Cycle: Oxidative Stress and Neurotoxicity in Neurodegenerative Diseases
- Regulation of PPAR-γ coactivator-1α and its implication in Mitochondrial Function and Neurodegenerative Diseases
- Grueneberg Ganglion: An Unexplored Site for Intranasal Drug Delivery in Alzheimer's Disease
- Tipping the PARylation scale: Dysregulation of PAR signaling in Huntington and neurodegenerative diseases
- Evaluating the neuroprotective potential of Mucuna pruriens and Boswellia serrata in Huntington's disease: an integrative bioinformatics approach
- O-GlcNAcylation: A molecular switch linking brain health to neurodegeneration
- Role of voltage-dependent anion channel 1 in neurodegeneration: Mechanisms, implications, and therapeutic potential
- Advances in Neurodegenerative Disease Therapy: Stem Cell Clinical Trials and Promise of Engineered Exosomes
- Bidirectional communication between the gut microbiota and the central nervous system
- Comparative analysis of RAN translation from CAG repeats within the Huntingtin coding sequence
- Analysis of cancer mutations introduced into the Drosophila Notch Negative Regulatory Region uncovers a diversity of regulatory outcomes
- Deciphering the unique autoregulatory mechanisms and substrate specificity of the understudied DCLK3 kinase linked to neurodegenerative diseases
- The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation
- Neuropathological Characterisation of McLeod Syndrome With a Proposed New Grading System
- A simplified hybrid capture approach retains high specificity and enables PCR-free workflow
- The emerging role of biomaterial applications in cerebral lymphatic surgical interventions: A narrative review
- Boosting the Therapeutic Potential of Extracellular Vesicles Derived From Mesenchymal Stem Cells via Advanced Preconditioning for Neurodegenerative Disorders
- Advancements in extracellular vesicle therapy for neurodegenerative diseases
- TDP-43 proteinopathies and neurodegeneration: insights from Caenorhabditis elegans models
- How Early Does Anosognosia Begin in Huntington's Disease?
- Sleep in neurodegenerative diseases: A focus on melatonin, melanin-concentrating hormone and orexin
- Profiling the landscape of cysteine posttranslational modifications in brain aging and neurodegeneration
- CCR5 as a key modulator in neurocognitive disorders
- Early Metabolic Alterations in Cerebrospinal Fluid Fatty Acid Profiles Linked to Cognitive Decline and All-Cause Dementia
- Erratum to'Neuroprotective and gut health benefits of Ugni molinae in preclinical Huntington's disease models' [Experimental Neurology, Volume 393 (2025) 115406]
- Overcoming the Blood-Brain Barrier: Advanced Strategies in Targeted Drug Delivery for Neurodegenerative Diseases
- Animal Models for the Study of Neurological Diseases and Their Link to Sleep
- Cathepsins in Neurological Diseases
- Emotional speech markers of psychiatric disturbance in Huntington's disease
- Probability and Neurodegeneration: Alzheimer's Disease and Huntington's Disease
- Progress on 3-Nitropropionic Acid Derivatives
- Musical Distractions: Music-Based Rhythmic Auditory Stimulation Fails to Improve Gait in Huntington's Disease
- Sequestering sequestosome 1 via S-acylation in autophagy, Huntington disease, and beyond
- AI-Enhanced Transcriptomic Discovery of Druggable Targets and Repurposed Therapies for Huntington's Disease
- Therapeutic strategies for Huntington's disease: current approaches and future direction
- Optical coherence tomography - A possible biomarker in early huntington's disease
- Criminal minds in dementia: A systematic review and quantitative meta-analysis
- The Proteostasis Network in Proteinopathies: Mechanisms and Interconnections
- Corrigendum to Transplanted human striatal progenitors exhibit functional integration and modulate host circuitry in a Huntington's disease animal model [Pharmacol. Res. volume 219:107905 (2025)]
- Cognitive Endpoints in Huntington's Disease Trials: A Conceptual Framework for Clinical Meaningfulness
- Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets
- Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington's disease
- Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models
- Mapping iron content and white matter integrity in the anterior thalamic radiations across Huntington's disease stages
- Rho kinase isoforms in neurodegeneration: from cellular functions to therapeutic targets
- Investigating Curvature Sensing by the Nt17 Domain of Huntingtin Protein
- Understanding the relationship between patient-reported outcome measures, clinician-rated assessments, and performance-based measures (cognitive tests and device-based estimates) of symptoms and functioning in people with Huntington's disease
- Role of Calmodulin in Neurodegeneration and Neuroprotection
- Metformin decreases RAN proteins, rescues splicing abnormalities and improves behavioral phenotypes in SCA8 BAC mice
- The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer's disease
